Atlas Trials

Study on the Bioequivalence of Amisulpride Orally Disintegrating Tablets in Human Body

Clinical trial NCT06066112 · UNKNOWN

Trial details

NCT number
NCT06066112
Sponsor
The Affiliated Hospital of Qingdao University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
BioequivalenceSchizophrenia
Start date
2023-09-20
Primary completion
2023-10-07
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.